Literature DB >> 2523759

Percutaneous transluminal angioplasty of abdominal aortic stenoses.

A Odurny1, R F Colapinto, K W Sniderman, K W Johnston.   

Abstract

Percutaneous transluminal angioplasty (PTA) was performed on 25 patients with localized distal abdominal aortic stenoses. All patients were smokers and all complained of bilateral lower limb claudication. Eleven patients had small distal aortas and iliac vessels. Technically successful dilatation was achieved in all patients. Long-term follow-up was available on 17 of the patients. The mean follow-up period was 38 months. Cumulative patency at 5 years was 70%. Thirteen patients remain asymptomatic 15-83 months following PTA. Late failure occurred in 4 patients, 1-38 months following PTA. No complications related to PTA were experienced. PTA of localized aortic stenoses is a safe alternative to surgery and should be the treatment of choice in this condition.

Entities:  

Mesh:

Year:  1989        PMID: 2523759     DOI: 10.1007/bf02577116

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  14 in total

1.  Examining survival data.

Authors:  A J Coldman; J M Elwood
Journal:  Can Med Assoc J       Date:  1979-10-20       Impact factor: 8.262

2.  Transluminal angioplasty of the abdominal aorta.

Authors:  D Heeney; J Bookstein; E Daniels; M Warmath; J Horn; W Rowley
Journal:  Radiology       Date:  1983-07       Impact factor: 11.105

3.  Abdominal aortic angioplasty: a case report with angiographic follow-up.

Authors:  G Hudon; R Bonan; Y Hébert
Journal:  J Can Assoc Radiol       Date:  1982-12

4.  Percutaneous transluminal abdominal aortic angioplasty.

Authors:  J H Grollman; M Del Vicario; A K Mittal
Journal:  AJR Am J Roentgenol       Date:  1980-05       Impact factor: 3.959

5.  Nonsurgical aortoplasty in Leriche syndrome.

Authors:  G Velasquez; W Castaneda-Zuniga; A Formanek; C Zollikofer; A Barreto; D Nicoloff; K Amplatz; A Sullivan
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

6.  Segmental aortic occlusion: An unusual lesion found in menopausal women.

Authors:  M J Costantino; R B Smith; G D Perdue
Journal:  Arch Surg       Date:  1979-03

7.  Atherosclerosis and the hypoplastic aortoiliac system.

Authors:  D A DeLaurentis; P Friedman; C C Wolferth; A Wilson; D Naide
Journal:  Surgery       Date:  1978-01       Impact factor: 3.982

8.  Percutaneous transluminal angioplasty of the lower abdominal aorta.

Authors:  N Charlebois; G Saint-Georges; G Hudon
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

9.  Arteriographic measurement of the abdominal aorta, iliac, and femoral arteries in women with atherosclerotic occlusive disease.

Authors:  J L Cronenwett; H E Garrett
Journal:  Radiology       Date:  1983-08       Impact factor: 11.105

10.  A thirty-year survey of the reconstructive surgical treatment of aortoiliac occlusive disease.

Authors:  D E Szilagyi; J P Elliott; R F Smith; D J Reddy; M McPharlin
Journal:  J Vasc Surg       Date:  1986-03       Impact factor: 4.268

View more
  4 in total

1.  Stent placement for failed angioplasty of aortic stenoses: report of two cases.

Authors:  D Vorwerk; R W Günther; K Bohndorf; P Keulers
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

Review 2.  Iliac arteries: how registries can help improve outcomes.

Authors:  Charles Ross Tapping; Raman Uberoi
Journal:  Semin Intervent Radiol       Date:  2014-12       Impact factor: 1.513

3.  Infrarenal aortic stents: initial clinical experience and angiographic follow-up.

Authors:  A L Long; J C Gaux; A C Raynaud; J M Faintuch; J Y Pagny; P Lacombe; J N Fiessinger; J Y Relland; B M Beyssen
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

4.  Percutaneous transluminal aortic angioplasty: early and late results.

Authors:  B Morag; A Garniek; A Bass; J Schneiderman; R Walden; Z J Rubinstein
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jan-Feb       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.